Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia

scientific article published on 3 January 2006

Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0033291705006756
P698PubMed publication ID16388703

P50authorMatcheri S KeshavanQ48067656
P2093author name stringJohn A Sweeney
James L Reilly
Margret S H Harris
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)485-494
P577publication date2006-01-03
P1433published inPsychological MedicineQ7256364
P1476titleLongitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia
P478volume36

Reverse relations

cites work (P2860)
Q47787028Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis
Q91806336Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders
Q26991569An Overview of the Association between Schizotypy and Dopamine
Q34619903Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit
Q35182103Cognitive control of gaze in bipolar disorder and schizophrenia.
Q36426332Consider the context: blocked versus interleaved presentation of antisaccade trials
Q36926053Disorders of saccades.
Q33888153Effect of second-generation antipsychotics on cognition: current issues and future challenges
Q46201976Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia
Q35202584Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study
Q34656464Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia
Q57978272Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy
Q35215692Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia
Q34048579Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories
Q37945156Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.
Q34127765Evidence from cluster analysis for differentiation of antisaccade performance groups based on speed/accuracy trade-offs
Q30828715Failure to mobilize cognitive control for challenging tasks correlates with symptom severity in schizophrenia
Q37699383Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery
Q30442031Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia
Q50737831Neural correlates of impaired volitional action control in schizophrenia patients.
Q35133191Neurobehavioral Abnormalities in First-Degree Relatives of Individuals With Autism
Q37203360Neurobiology of the early course of schizophrenia
Q30488649Neurocognitive allied phenotypes for schizophrenia and bipolar disorder
Q37076346Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia
Q34235346Oculomotor and pupillometric indices of pro- and antisaccade performance in youth-onset psychosis and attention deficit/hyperactivity disorder
Q35173870Pharmacological treatment effects on eye movement control
Q42110133Psychiatry, neurology, and the role of the cerebellum
Q36630970Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia
Q33803943Reduced functional connectivity in a right-hemisphere network for volitional ocular motor control in schizophrenia
Q34425198Response inhibition and response monitoring in a saccadic countermanding task in schizophrenia
Q35404577Response inhibition and response monitoring in a saccadic double-step task in schizophrenia
Q37472068Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression
Q38923332Schizophrenia and Infections: The Eyes Have It.
Q46395890Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades
Q38646709The Stochastic Early Reaction, Inhibition, and late Action (SERIA) model for antisaccades.
Q36522001The antisaccade task as a research tool in psychopathology: a critical review
Q30437913The effects of ketamine and risperidone on eye movement control in healthy volunteers
Q44813180The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease
Q38860355The neural underpinnings of cognitive flexibility and their disruption in psychotic illness
Q24644046The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences
Q37308096The tell-tale tasks: a review of saccadic research in psychiatric patient populations
Q34077386Top-down control of visual sensory processing during an ocular motor response inhibition task
Q30450648Turning it upside down: areas of preserved cognitive function in schizophrenia
Q43762923Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
Q31112471fMRI studies of eye movement control: investigating the interaction of cognitive and sensorimotor brain systems